SUCROSOMIAL TECHNOLOGY

A unique delivery system, a revolution in the field of nutraceuticals, which guarantees maximum efficacy in transporting and absorbing essential bioactive compounds.

CETYLATED FATTY ACIDS

A patented solution designed to enhance joint and muscle mobility, known for its exceptional skin penetration and rapid absorption.

PRODUCTS

PharmaNutra products are designed to provide a safe and effective response to health and well-being requirements at any stage of life.
R&D

We are committed to advancing nutraceutical science by developing effective, high-quality supplements and medical devices.

In our laboratories, we use cutting-edge research models to drive innovation, blending solid scientific methods with a forward-thinking approach to technology and patents. PharmaNutra's research focuses on key health areas, especially addressing nutritional deficiencies in minerals and vitamins, supporting muscle and joint health and enhancing functional and sports nutrition.

MORE
THERAPEUTIC AREAS

Our scientific research

NEWS

Inform, innovate, inspire: putting health first

Stay updated with the latest from PharmaNutra: scientific insights, events, groundbreaking products and updates tailored to support your professional practice.
Raw materials

The effects of calcium on energy metabolism and the benefits of UltraCal®

Read more
News & Events

Cetilar® and Obiettivo 3 together towards Tokyo 2020

Read more
News & Events

World Partners Convention 2018: a borderless success

Read more
News & Events

PharmaNutra main character of the Healthcare Forum 2018

Read more
Raw materials

ATURA: plant protein concentrates

Read more
Raw materials

Vitafoods 2022: Alesco returns to exhibiting at the most important European nutraceutical trade fair

Read more
News & Events

PharmaNutra participates in the second edition of Mediobanca’s Italian Mid Cap Conference

Read more
News & Events

Vitamina Cetilar fourth place in Porto Cervo

Read more
News & Events

We Are Cetilar: in Parma for the second stage of the year

Read more
News & Events

Pharmanutra Group at Vitafoods Europe 2017

Read more
Iron deficiency

New scientific studies on Sucrosomial® Technology applied to iron

Read more
Raw materials

Alesco-PharmaNutra Merger: from July 2024, Alesco will become a business division of the Group

Read more
Iron deficiency

The sucrosomial iron technology in Zurich for “The European Iron Club 2018”

Read more
Raw materials

Alesco and Polaris: a new partnership to continue the distribution of Algal DHA

Read more
Muscles and joints

Diathermy and cetylated fatty acids (CFAs): a winning combination against muscle pain

Read more